Document is current

Article History

Received: 3 July 2025

Accepted: 27 October 2025

First Online: 11 November 2025

Declarations

:

: Maria del Pilar Fortes Soto and Alfonso De Lossada Juste are employees of Pfizer (Spain). Alba Bellmunt and Neus Vidal-Vilar disclosed that they are paid consultants at Outcomes’10 (a ProductLife Group Company), a company paid by Pfizer to assist with the writing of this scientific letter. Pedro Herranz Pinto has served as investigator and/or speaker for Abbvie, Almirall, Bristol Myers Squibb, Janssen, Leopharma, Lilly, Novartis, Pfizer, Regeneron, Sandoz, Sanofi, and UCB Pharma. Minia Campos Domínguez has served as speaker for Sanofi, Almirall and Abbvie, as investigator for Abbvie, has participated in advisory boards for Pfizer, and has received funding for training activities from Galderma. Rosa María Romero Jiménez has served as speaker for Sanofi and Novartis.

: Data are available from the corresponding author upon reasonable request.

: Not applicable.

: Not applicable.

: Not applicable.

: The data presented in this study are available within the article or in the Supporting Information Materials. The model used in this study is available from the corresponding author upon reasonable request.

: All authors contributed to the conception of the study and AB performed the analysis. All authors drafted the original research letter and made substantial contributions to the original draft and the final version. All authors reviewed and approved the final version for submission. All authors agreed to be responsible for all aspects of the work.